Portfolio company
Bexorg
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Bexorg provides an AI-powered perfusion platform using post-mortem human brains to facilitate central nervous system drug discovery for pharmaceutical and academic researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BrainZell
The company develops brain organoid models and computational tools for pharmaceutical firms to discover central nervous system drugs and test their efficacy.
Itay&Beyond
The company develops patient-derived brain organoids and an artificial intelligence platform for pharmaceutical firms to test drug efficacy for neurological and psychiatric disorders.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Archean Sciences
Archean Sciences develops brain-on-a-chip systems using living human neurons to provide drug testing and energy-efficient computing for pharmaceutical and artificial intelligence firms.
Bioqore
The company develops AI-driven bioprocessing models and automated wet lab services to optimise drug manufacturing conditions for biotechnology and pharmaceutical companies.
Olfera
Olfera develops biopharmaceutical delivery solutions using an olfactory platform to transport drugs directly to the brain for patients with neurological conditions.
Verge
This company provides a technology platform using artificial intelligence and human genomics to discover and develop drugs for patients with neurodegenerative diseases.
RebrAIn
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
